Profound Medical (PROF) EBIAT (2023 - 2025)
Historic EBIAT for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$8.0 million.
- Profound Medical's EBIAT rose 1482.11% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.3 million, marking a year-over-year increase of 4447.16%. This contributed to the annual value of -$27.8 million for FY2024, which is 179.01% up from last year.
- According to the latest figures from Q3 2025, Profound Medical's EBIAT is -$8.0 million, which was up 1482.11% from -$15.7 million recorded in Q2 2025.
- Over the past 5 years, Profound Medical's EBIAT peaked at $7.4 million during Q2 2023, and registered a low of -$48.0 million during Q4 2023.
- In the last 3 years, Profound Medical's EBIAT had a median value of -$6.9 million in 2024 and averaged -$8.2 million.
- The largest annual percentage gain for Profound Medical's EBIAT in the last 5 years was 8969.01% (2024), contrasted with its biggest fall of 26831.42% (2024).
- Over the past 3 years, Profound Medical's EBIAT (Quarter) stood at -$48.0 million in 2023, then skyrocketed by 89.69% to -$4.9 million in 2024, then crashed by 61.25% to -$8.0 million in 2025.
- Its last three reported values are -$8.0 million in Q3 2025, -$15.7 million for Q2 2025, and -$10.7 million during Q1 2025.